Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H27NO4 |
Molecular Weight | 333.422 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC3=C(C(OC)=C(OC)C=C3)[C@@]4(CCN1C)C[C@H](O)CC[C@@]24O
InChI
InChIKey=LCAHPIFLPICNRW-SVYNMNNPSA-N
InChI=1S/C19H27NO4/c1-20-9-8-18-11-13(21)6-7-19(18,22)15(20)10-12-4-5-14(23-2)17(24-3)16(12)18/h4-5,13,15,21-22H,6-11H2,1-3H3/t13-,15-,18-,19-/m1/s1
Molecular Formula | C19H27NO4 |
Molecular Weight | 333.422 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/405065Curator's Comment: description was created based on several sources, including, http://rusnewsjournal.com/4/522081/
Sources: http://www.ncbi.nlm.nih.gov/pubmed/405065
Curator's Comment: description was created based on several sources, including, http://rusnewsjournal.com/4/522081/
Drotebanol is an opioid drug developed in Japan and used for the treatment of cough under the name Metebanyl, although it is now no longer used. Drotebanol possess CNS activity and is considered to be narcotic in many countries.
CNS Activity
Originator
Sources: http://www.ncbi.nlm.nih.gov/pubmed/5462594
Curator's Comment: Now is the part of Daiichi Sankyo.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: http://www.ncbi.nlm.nih.gov/pubmed/405065 |
Primary | METEBANYL Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Pharmacological studies of a new potent antitussive agent, 14-hydroxy-dihydro-6 beta-thebainol-4-methyl ether (oxymethebanol)]. | 1969 Mar 20 |
|
[Absorption, distribution, excretion and metabolism of 14-hydroxydihydro-6-beta-thebainol 4-methylether (oxymethebanol)]. | 1970 Jan |
|
Dependence potential of drotebanol, codeine and thebaine tested in rhesus monkeys. | 1977 Jan-Mar |
|
[Pharmacological studies on the cough-like reflex induced by chemical stimulation (author's transl)]. | 1978 Apr |
|
Effect of the centrally acting antitussives on ascites tumor cells. | 1983 Apr |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/405065
Oral doses of 4 mg/person
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:51:08 GMT 2023
by
admin
on
Sat Dec 16 15:51:08 GMT 2023
|
Record UNII |
7RS2Q8MCK8
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
||
|
DEA NO. |
9335
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB06416MIG
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
2958
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
DB01547
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
DTXSID30101790
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
DROTEBANOL
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
C80575
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104603
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
m1126
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | Merck Index | ||
|
3176-03-2
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
3168
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
C001387
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
5463863
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
100000090360
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY | |||
|
7RS2Q8MCK8
Created by
admin on Sat Dec 16 15:51:08 GMT 2023 , Edited by admin on Sat Dec 16 15:51:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |